IDH1 and neoplasm: The results showed that the proportion of IDHR132H+ tumor cells had a predictive AUC of 74.6% for IDH mutations, with the best cutoff point at 0.0%, indicating that IDHR132H, as a mutation specifically occurring in tumor cells, has high sensitivity and specificity for mutation status.